Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commission Adopts Proposal For EU MDR Changes, Sets Out New Transition Deadlines

Executive Summary

The European Commission is now a step closer to implementing legislation that will see staggered delays for the application of the MDR in a bid to forestall medical devices shortages across the EU, with even longer extensions proposed than previously expected.

You may also be interested in...



Various Options For Legacy Products Whose Conformity Assessment Certificates Have Expired

How does the European Commission’s proposal to amend the Medical Device Regulation to extend the transition periods for legacy devices impact devices that may seem lost to the market? 

European Commission Invites Comments On Its Critical MDR Proposal

The EU is looking at extending transition deadlines for compliance under the Medical Device Regulation as a matter of urgency. Now the European Commission is inviting feedback on its proposed measures.

European Regulatory Roundup, December 2022: Repositioning The MDR For A Better Year In 2023

2022 ended on as positive a note as could have been wished for in terms of setting the scene for a more effective implementation of the MDR. But has too much damage already been done?

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel